Merck raises annual profit outlook as Keytruda drives profit beat

Merck said it now expects full-year adjusted profit of between $5.91 and $6.01 per share, compared with its prior forecast of between $5.63 to $5.78 per share. For 2020, Merck now expects an unfavorable impact to revenue of about $2.35 billion due to the pandemic, up from $1.95 billion it had initially estimated. Excluding items, Merck earned $1.74 per share, beating analysts’ average estimates of $1.44 per share, according to IBES data from Refinitiv. …read more

Source:: Yahoo Finance